GLPG Bathi mangsa ngarep Galapagos N.V.

Simbol resmi perusahaan Galapagos N.V. (GLPG)

The target profit level of Galapagos NV (GLPG) exhibits volatility, which is mitigated by the company's authority in developing cell therapies. Stability is provided by the high scalability of patent solutions and a substantial cash reserve protecting its R&D. The current metric is fixed at , allowing investors to promptly track the dynamics of expected business revenues and assess the risks of a market revaluation of the asset.

glpg.com (GLPG): Bathi resik sing dikarepake saka 04.07.2022 nganti 18.11.2026

Galapagos Genomics - rincian analitis lan metrik utama (GLPG)

- rega saham lan konsensus proyeksi valuasi:
Analisis fundamental perusahaan:GLPG, Galapagos
Produk dadi Galapagos N.V.

This indicator measures the dynamics of expected net income, making it possible to determine whether the price decline is a temporary correction or the result of fundamental margin degradation. Analyzing prospective net profit helps assess business resilience to shocks, which is critical for Galapagos NV (GLPG) during the development of original drugs and CAR-T therapies, where the success of innovations directly determines future capitalization.

Analisis pesaing Galapagos NV

Bathi mangsa ngarep HLN|Proyeksi bathi mangsa ngarep Kenvue Corp|Bathi mangsa ngarep VRNA (Verona Pharma Corp)|MENS (Jyong Bio) - Penghasilan resik sing dikarepake|Bathi sing dikarepake Ligand Pharmaceuticals Incorporated LGND|Amneal (AMRX) - Bathi resik sing dikarepake|PRGO: Bathi mangsa ngarep|Alvotech SA - Bathi resik mangsa ngarep|LQDA: Proyeksi bathi mangsa ngarep|ANI Pharma - Penghasilan resik sing dikarepake|MNKD (MannKind Corp) - Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake amphastar.com AMPH|Bathi sing dikarepake Pacira BioSciences, Inc. (PCRX)|SPRY (ARS Pharmaceuticals, Inc.) - Penghasilan resik sing dikarepake|Theravance Biopharma, Inc. - Bathi mangsa ngarep|Proyeksi bathi mangsa ngarep Aquestive Corp AQST|scPharmaceuticals - Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake tectonictx.com|Tonix Pharmaceuticals Inc. (TNXP) - Bathi sing dikarepake|SXTC - Prakiraan bathi perusahaan|Bathi sing dikarepake eupraxiapharma.com|BHST: Penghasilan resik sing dikarepake|Bathi mangsa ngarep EXOZ (Invizyne Technologies)|ORMP - Bathi resik sing dikarepake|Proyeksi bathi mangsa ngarep ENTX (Entera Bio Ltd)|Proyeksi bathi mangsa ngarep MindWalk Holdings, Inc. HYFT|ABVC BioPharma, Inc - Proyeksi bathi mangsa ngarep|CPIX: Bathi sing dikarepake|QNTM (Quantum BioPharma Ltd) - Bathi mangsa ngarep|Prakiraan bathi resik FGEN|Bathi sing dikarepake Telomir Pharmaceuticals|RANI: Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep SNYR|Bathi mangsa ngarep Rallybio Corp RLYB|Bathi sing dikarepake Lexaria Bioscience Corp. LEXX|Prakiraan bathi perusahaan pulmatrix.com (PULM)|Pheton Holdings Limited - Proyeksi bathi mangsa ngarep|Bathi forward APM|LYRA (Lyra Therapeutics Inc.) - Bathi mangsa ngarep|IBO - Prakiraan bathi perusahaan|Bathi mangsa ngarep TNFA|Prakiraan bathi resik YCBD (cbdmd.com)|Bathi mangsa ngarep PRFX (PainReform Ltd)|CYTO: Bathi forward|Proyeksi bathi mangsa ngarep LIPO (lipella.com)|Bathi resik mangsa ngarep OPTN (OptiNose Corp)|PIRS: Bathi mangsa ngarep|PROC - Proyeksi bathi mangsa ngarep|PTPI: Proyeksi bathi mangsa ngarep|Qilian International Holding Group (QLI) - Proyeksi bathi mangsa ngarep|SLRN (ACELYRIN, Inc.) - Proyeksi bathi mangsa ngarep|TFF Pharmaceuticals (TFFP) - Prakiraan bathi perusahaan